Integral Diagnostics Ltd. (AU:IDX) has released an update.
Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Capitol Health Limited has received Federal Court approval for its merger with Integral Diagnostics Limited, set to become legally effective on December 11, 2024. Following this, Capitol’s shares will be suspended from trading on the ASX, and new Integral Diagnostics shares will begin trading on December 12, 2024. The merger aims to enhance diagnostic imaging services across Australia.
For further insights into AU:IDX stock, check out TipRanks’ Stock Analysis page.